combination treatment of the human glioblastoma xenograft using bcnu produced significant ilss of 105 and 119 % and was superior to single-modality treatment with a drug dose of 10 mg/kg and radiation doses of 540 and 800 rads , respectively .
C0017636
glioblastoma
C0007257
bcnu